Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases

Journal of Neural Transmission, Supplement

Volumn , Issue 71, 2006, Pages 39-43

  Sofic, Emin ^a   Sapcanin, A ^a   Tahirovic, I ^a   Gavrankapetanovic, I ^a   Jellinger, K ^b   Reynolds, G P ^c   Tatschner, T ^d   Riederer, P ^d  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b GENERAL HOSPITAL LINZ   (Austria)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER SULFATE; FREE RADICAL; HYDROXYL RADICAL; OXYGEN RADICAL; PEROXY RADICAL; PHOSPHATE BUFFERED SALINE; ANTIOXIDANT;

ADULT; AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPSY; BRAIN TISSUE; CAUDATE NUCLEUS; CENTRIFUGATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; PARKINSON DISEASE; PH; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TEMPORAL LOBE; ANALYSIS OF VARIANCE; BRAIN; CADAVER; CASE CONTROL STUDY; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SPECTROPHOTOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSTMORTEM CHANGES; SPECTROPHOTOMETRY;

EID: 34248531658     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-33328-0_5     Document Type: Article

References (33)

1. Berg D, Youdim MB, Riederer P (2004) Redox imbalance. Cell Tissue Res 318: 201-213
2. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AMG, Buttetfield DA (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedrich's ataxia. J Neurol Sci 233: 145-162
3. Cao G, Alessio HM, Cutler RG (1993) Oxygen-radical absorbance capacity assay for antioxidants. Free Rad Biol Med 14: 303-311
4. Cao G, Verdon C, Wu AHB, Wang H, Prior RL (1995) Automated oxygen radical absorbance capacity assay using the COBAS FARA II. Clin Chem 41: 1738-1744
5. Cao G, Giovanoni M, Prior R (1996) Antioxidant capacity decreases during growth but not aging in rat serum and brain. Arch Gerontol Geriatr 22: 27-37
6. Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet 341: 1219-1220
7. Dexter DT Carter CH, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389
8. Ghiselli A, Serafini M, Maiani G, Assini E, Ferro-Luzzi A (1995) A fluorescence-based method for measuring total plasma antioxidant capacity. Free Rad Biol Med 18: 29-36
9. Glazer AN (1990) Phycoerythrin fluorescence-based assay for reactive oxygen species. Methods Enzymol 186: 161-168
10. Goetz M, Kuenig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neural degeneration. Pharmac Ther 63: 37-122
11. Goetz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K, Hebenstreit G, Froelich L, Beckmann H, Riederer P (1992) Susceptibility of Brains from Patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 3: 213-222
12. Gsell W, Conrad R, Hickethier M, Sofic E, Froelich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P (1995) Decreased catalase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64: 1216-1223
13. Halliwell B (1989) Oxidants and central nervous system: some fundamental questions. Acta Neurol Scand 126: 23-33
14. Halliwell B, Gutteridge JMC (1984) Oxygen toxicity, transition metals and disease. Biochem J 219: 1-14
15. Jenner P, Olanow CW (1996) Oxidative stress and the pathogenesis of Parkinsons disease. Neurology 47 [6 Suppl 3]: S161-S170
16. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
17. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150: 40-44
18. Mazzio E, Soliman K (2004) Glioma cell antioxidant capacity relative to oxygen species produced by dopamine. J Appl Toxicol 24: 99-106
19. Montine TJ, Morrow JD (2005) Fatty acid oxidation in the pathogenesis of Alzheimer's disease. Am J Pathol 166: 1283-1289
20. Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G (2005) Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J Neural Transm 112: 921-923
21. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch-Woodill M, Huang D, Ou B, Jacob R (2003) Assays for hydrophilic and lipophilic antioxidant capacity [oxygen radical absorbance capacity (ORAC-FL)] of plasma and other biological and food samples. J Agric Food Chem 21, 51: 3273-3279
22. Reichmann H, Janetzky B (2000) Mitochondrial dysfunction - a pathogenetic factor in Parkinson's disease. J Neurol 247 [Suppl 2]: 63-68
23. Riederer P, Sofic E, Rausch WD, Kruzik P, Youdim MBH (1985) Dopaminforschung heute und morgen - L-DOPA in der zukunft. In: Riederer P, Umek H (eds) L-DOPA-Substitution der Parkinson-Krankheit. Geschichte, Gegenwart-Zukunft. Springer Verlag, Wien, New York, pp 127-144
24. Riederer P, Sofic E, Moll G, Freyberger A, Wichart I, Gsell W, Jellinger K, Hebenstreit G, Youdim MBH (1990) Senile dementia of Alzheimer's type and Parkinson's disease: neurochemical overlaps and specific differences. In: Dostert P, Riederer P, Strolin M, Roncucci R (eds) Neurochemistry of DAT and PD. New Vistas in Drug Research, vol. 1. Springer-Verlag, Austria, pp 221-232
25. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brain. J Neurochem 52: 515-520
26. Serra JA, Dominquez RO, de Lustig ES, Guareshi EM, Famulari AL, Bartolome EL, Marschoff ER (2001) Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in Living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm 108: 1135-1148
27. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increased iron(III) and total iron content in postmortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199-205
28. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978-982
29. Sofic E, Rustembegovic A, Kroyer G, Cao G (2002) Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 109: 711-719
30. Valko M, Morris H, Cronin MTD (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12: 1161-1208
31. Wayner DDM, Burton GW, Ingold K, Locke S (1985) Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett 187: 33-37
32. Whitehead TP, Thorpe GHG, Maxwell SRJ (1992) Enhanced chemiluminiscent assay for antioxidant capacity in biological fluids. Anal Chim Acta 266: 265-277
33. Zecca L, Youdim MB, Riederer P, Conor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873